Johnson & Johnson’s mass production of sterile sutures and other products ushered in the widespread practice of modern antiseptic surgery that dramatically raised survival rates.

SURGICEL made history as the first oxidized regenerated cellulose hemostat introducing new options for clinicians to manage surgical bleeding.

The first synthetic sterile suture, PROLENE Polypropylene Suture remains the gold standard for cardiac bypass surgery for its strength, secure knotting and biocompatibility.

This game-changing skin stapler introduced disposable instruments to the OR. The success of disposable PROXIMATE opened the door to new innovations for open and minimally invasive procedures.

Used by surgeons around the world today for general surgery use, Coated VICRYL (polyglactin 910) Suture balances the surgeon’s need for slide with knot security in achieving reliable approximation and closure.

First Laparoscopic Cholecystectomy and development of Minimally Invasive solutions

Founded in Ohio, Ethicon Endo-Surgery brought surgical technologies and solutions including staplers, energy devices and trocars.

Our pioneering live telesurgery, Dr. J. Barry McKernan performed a laparoscopic cholecystectomy at the American College of Surgeons’ annual meeting introduced clinicians to the possibilities of distance learning.

DERMABOND Topical Skin Adhesive paved the way for replacing sutures with a new generation of skin closure solutions.¹

Our launch of the first 5mm HARMONIC shears allowed surgeons to dissect, cut and coagulate with one ultrasonic energy device that could also reduce thermal damage and preserve tissue function.

Committed to shaping the future of surgery in the fight against obesity and metabolic diseases and helping to elevate the standard of care through research and evidence, best-in-class education and training, innovative products and expanding patient access to care.

The first commercially available antibacterial suture, Coated VICRYL Plus Antibacterial (polyglactin 910) Suture broke new ground in addressing a known risk factor for surgical-site infections (SSI) by preventing bacterial colonization of the suture.

The first powered endocutter with system-wide compression and stability helped to fuel the revolution to minimally invasive approaches. Virtually effortless firing reduces unwanted movement of distal tip, potentially reducing damage to target and surrounding tissue and organs compared to manual stapler firings.^1,*

Verb Surgical, founded in 2015, is developing a digital surgery platform built with technology from Verily (formerly Google Life Sciences) and Ethicon Endo-Surgery, Inc.  Verb’s platform will include robotics, visualization, advanced instrumentation, data analytics, and connectivity.

Ethicon acquires NeuWave Medical, Inc., a company that manufactures and markets minimally invasive soft-tissue microwave ablation systems. This acquisition is consistent with the strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology.

The acquisition of Megadyne’s innovative portfolio of electrosurgical tools represents a major step forward in Ethicon’s goal to deliver the most comprehensive suite of intelligent energy solutions that enhance precision and efficiency in the operating room.